-
February 22, 2022 Irwin Naturals’ Mission to Make Ketamine Therapy Affordable for the MassesThe revered wellness brand wields proven business savvy to innovate, disrupt and equalize through its...
-
January 28, 2022 Psychedelic Business Spotlight — January 28This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one...
-
January 19, 2022 Majority of Mental Health Patients Support Access to Psychedelics, Survey FindsAmericans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety,...
-
January 18, 2022 Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary TechnologyThe technology may be more broadly used in the future for neuroscientific or physiological studies...
-
January 14, 2022 Psychedelic Business Spotlight — January 14This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine...
-
January 12, 2022 Ketamine Trial for Alcohol Use Disorder Delivers Very Promising ResultsAwakn Life Sciences' Head of Ketamine-Assisted Therapy, Professor Celia Morgan, says world’s first controlled trial...
-
January 7, 2022 Is ‘The Trip’ Essential to The Psychedelic Experience?Biology and experience are tough to separate, but some researchers are exploring the possibility of...
-
December 29, 2021 Interview with Matt Stang, CEO of Delic CorpCo-Founder and CEO, Matt Stang, gives us an overview of the company's clinics, Delic Labs...
-
December 28, 2021 Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More ApplicationsPsychedelic Spotlight speaks to a Field Trip Health patient and a psychotherapist, whose experiences suggest...
-
November 29, 2021 Combining Psychedelics: Is It Safe?Mixing psychedelics goes by many names in pop culture: hippie flipping (MDMA and mushrooms) and...
